EICKELMANN, PETER,MARK, MICHAEL,SEMAN, LEO JOHN,THOMAS, LEO,BROEDL, ULI,GREMPLER, ROLF
申请号：
PL10703288
公开号：
PL2395983T3
申请日:
2010.02.11
申请国别(地区):
PL
年份:
2020
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
